Utilizing Multiplex ddPCR to Streamline Viral Gene Therapy Workflows
Learn why ddPCR, a relatively new form of PCR, offers distinct advantages for DNA and RNA quantification quantification over standard qPCR methods for viral vector…
Partnering for Success in Oncolytic Virus Development
Advance your oncolytic virus program with a partner built for speed, safety, and scale. This resource outlines how FUJIFILM Biotechnologies...
Scaling Up E. coli Processes with Confidence
A video with Jackie Swinbourne, Senior Principal Scientist at FUJIFILM Diosynth Biotechnology
Advancing Tomorrow’s Gene Therapies
A video about Advancing Tomorrow’s Gene Therapies with Dr Rebecca Abram at FUJIFILM Biotechnologies
Drug Product Filling Line for Large Scale Biologics
Learn More about our Drug Product Filling Line for Large Scale Biologics First Name(Required)Last Name(Required)Company Name(Required)Country(Required)United StatesUnited KingdomAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and...
Inclusion Bodies: Friends Or Foes? Development And Scale Up Of Insoluble, Microbially Expressed Biologics
A Webinar By Steve Loftus, Business Steering Group Leader for Microbial
Evaluating Biomanufacturing Possibilities to Meet Patient Needs
Drug sponsors must find the biomanufacturing strategy that can best accommodate uncertain and evolving demand forecasts in order to deliver innovative biologics that address blockbuster…
Application of Platform Approaches to the Development of Bispecific Antibodies
Finding the Perfect Balance Between Speed and Quality in Bispecific Antibody Production
Critical Steps to Optimize Viral Vector Manufacturing with CDMOs
Accelerate your viral vector programs with proven CDMO best practices that streamline development, safeguard quality, and control costs. This resource...